COG2 — Conserved Oligomeric Golgi Complex 2

COG2 — Conserved Oligomeric Golgi Complex 2

Introduction

COG2 (Conserved Oligomeric Golgi Complex 2) is a key component of the COG complex, a multi-subunit vesicle tethering apparatus essential for proper Golgi apparatus function and intracellular membrane trafficking. COG2 is a member of lobe A of the COG complex and plays a critical role in maintaining Golgi morphology and function.

Gene Information

<div class="infobox infobox-gene">
<table>
<tr><th>Symbol</th><td>COG2</td></tr>
<tr><th>Full Name</th><td>Conserved Oligomeric Golgi Complex 2</td></tr>
<tr><th>Chromosomal Location</th><td>Chr1q25.2</td></tr>
<tr><th>NCBI Gene ID</th><td>26986</td></tr>
<tr><th>UniProt ID</th><td>Q8N5I2</td></tr>
<tr><th>Associated Diseases</th><td>CDG II, Neurodegeneration, Alzheimer's Disease, Parkinson's Disease</td></tr>
</table>
</div>

Function

COG Complex Architecture

The COG complex consists of eight subunits (COG1-8) organized into two distinct lobes[@miller2019]:

• Lobe A (COG1-4): COG2 functions in this lobe, which is primarily involved in the early stages of retrograde trafficking
• Lobe B (COG5-8): Handles later stages of vesicle tethering and fusion

Golgi Retrograde Trafficking

COG2 is essential for retrograde vesicle transport between Golgi cisternae, ensuring the proper recycling of Golgi resident proteins and trafficking machinery components[@blackburn2019]. This process is vital for:

• Maintaining Golgi enzyme localization
• Quality control of protein glycosylation
• Proper sorting of proteins to their final destinations

COG2 — Conserved Oligomeric Golgi Complex 2

Introduction

COG2 (Conserved Oligomeric Golgi Complex 2) is a key component of the COG complex, a multi-subunit vesicle tethering apparatus essential for proper Golgi apparatus function and intracellular membrane trafficking. COG2 is a member of lobe A of the COG complex and plays a critical role in maintaining Golgi morphology and function.

Gene Information

<div class="infobox infobox-gene">
<table>
<tr><th>Symbol</th><td>COG2</td></tr>
<tr><th>Full Name</th><td>Conserved Oligomeric Golgi Complex 2</td></tr>
<tr><th>Chromosomal Location</th><td>Chr1q25.2</td></tr>
<tr><th>NCBI Gene ID</th><td>26986</td></tr>
<tr><th>UniProt ID</th><td>Q8N5I2</td></tr>
<tr><th>Associated Diseases</th><td>CDG II, Neurodegeneration, Alzheimer's Disease, Parkinson's Disease</td></tr>
</table>
</div>

Function

COG Complex Architecture

The COG complex consists of eight subunits (COG1-8) organized into two distinct lobes[@miller2019]:

• Lobe A (COG1-4): COG2 functions in this lobe, which is primarily involved in the early stages of retrograde trafficking
• Lobe B (COG5-8): Handles later stages of vesicle tethering and fusion

Golgi Retrograde Trafficking

COG2 is essential for retrograde vesicle transport between Golgi cisternae, ensuring the proper recycling of Golgi resident proteins and trafficking machinery components[@blackburn2019]. This process is vital for:

• Maintaining Golgi enzyme localization
• Quality control of protein glycosylation
• Proper sorting of proteins to their final destinations

Protein Glycosylation

The COG complex, including COG2, indirectly influences protein glycosylation by maintaining the localization and activity of glycosyltransferases in the Golgi[@freeze2012]. Proper glycosylation is essential for:

• Protein folding and stability
• Cell-cell recognition
• Receptor signaling

Role in Neurodegenerative Diseases

Alzheimer's Disease

COG2 dysfunction contributes to [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis through several mechanisms[@joshi2014]:

• Amyloid processing: Altered Golgi trafficking can affect [amyloid precursor protein](/entities/app-protein) (APP) processing and [amyloid-beta](/proteins/amyloid-beta) generation
• [Tau](/proteins/tau) pathology: Impaired glycosylation may influence tau phosphorylation and aggregation
• Synaptic dysfunction: Disrupted protein trafficking to synapses contributes to synaptic loss

Parkinson's Disease

The role of COG2 in [Parkinson's disease](/diseases/parkinsons-disease) includes[@hu2020]:

• [Alpha-synuclein](/proteins/alpha-synuclein) trafficking: Golgi dysfunction can alter alpha-synuclein processing and secretion
• Lysosomal function: COG2 deficiency impairs autophagosome-lysosome fusion, affecting protein clearance
• Mitochondrial quality control: Proper trafficking is needed for mitochondrial protein import and turnover

Other Neurodegenerative Conditions

COG2 has been implicated in[@liu2019]:

• Amyotrophic Lateral Sclerosis (ALS): Disrupted protein homeostasis in motor [neurons](/entities/neurons)
• Huntington's disease: Altered trafficking of mutant [huntingtin protein](/proteins/huntingtin)
• Frontotemporal dementia: Impaired stress granule dynamics

Structure

COG2 (Q8N5I2) is an 182 kDa protein with:

• Multiple coiled-coil domains for protein-protein interactions
• A C-terminal region essential for lobe A complex formation
• Putative membrane interaction domains

Clinical Significance

Congenital Disorders of Glycosylation (CDG)

Mutations in COG2 cause a form of congenital disorder of glycosylation type II (CDG-II), characterized by[@ng2018]:

• Severe developmental delay
• Neurological impairment including cerebellar atrophy
• Coagulation factor deficiencies
• Dysmorphic features

Therapeutic Targets

Understanding COG2 function offers potential therapeutic strategies:

• Small molecule enhancers: Compounds that improve COG complex stability
• Gene therapy: Restoring COG2 expression in affected tissues
• Modulation of Golgi stress response: Enhancing cellular adaptive mechanisms

See Also

• [COG1](/genes/cog1)
• [COG3](/genes/cog3)
• [COG4](/genes/cog4)
• [COG5](/genes/cog5)
• [COG6](/genes/cog6)
• [COG7](/genes/cog7)
• [COG8](/genes/cog8)
• [Golgi Apparatus](/mechanisms/golgi-apparatus)
• [Protein Trafficking](/mechanisms/protein-trafficking)

External Links

• [NCBI Gene: COG2](https://www.ncbi.nlm.nih.gov/gene/26986)
• [UniProt: COG2](https://www.uniprot.org/uniprot/Q8N5I2)

References